Prior Treatment With PD-0325901 With Ongoing Clinical Response
Conditions
Brief summary
The purpose of this study is to provide access for a single patient to PD-0325901 who was previously enrolled in a phase I clinical trial.
Interventions
DRUGPD-0325901
Sponsors
Sharp HealthCare
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Prior treatment with PD-0325901 with ongoing response
Exclusion criteria
* none
Countries
United States
Outcome results
None listed